DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
Applicant's election with traverse of Group I drawn to claims 1, 2, and 4 in the reply filed on 05/19/2026 is acknowledged. The traversal is on the ground(s) that amended claim 1 now shares the same or corresponding technical feature, thus there is unity of invention. This is not found persuasive because the amended shared technical feature does not make a contribution over the prior art as evidenced in the rejection of claim 1 below.
The requirement is still deemed proper and is therefore made FINAL.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1, 2, and 4 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Carter et al. (US Patent No. 6,382,469).
Re: Claim 1, Carter discloses the claimed invention including an actuator for connecting an injection tool (24) and a fluid delivery device for use in administering liquid formulations to plants or plant parts, wherein the fluid delivery device comprises a canister (12) that holds a liquid formulation, wherein the top of the canister has a lip (48), and wherein the fluid delivery device further comprises a stem (16) connected to the canister (Fig. 1, Col. 3, lines 33-35, canister lip); wherein the actuator comprises:
a frame (18) configured to couple to the canister of the fluid delivery device, the frame having one or more spreaders (52) configured to press on the lip of the canister and pull the frame against the lip (Figs. 1 & 7, Col. 5, lines 25-31, spreaders to press on the lip); and
an activator (22) coupled to the frame, wherein the activator is configured to move relative to the frame from an un-activated position (Fig. 7) to an activated position (Fig. 9) to trigger or activate the stem of the fluid delivery device, by pressing on the activator when the frame is coupled to the canister of the fluid delivery device, and wherein the activator is configured to mount the injection tool (24) (Fig. 1); and
wherein the frame has one or more predetermined breaking points coupling (120, 128) the activator to the frame in the un-activated position, and wherein the one or more predetermined breaking points are configured to break when the activator moves relative to the frame from the un-activated position to the activated position (Fig. 2, Col. 8, lines 20-30, breaking points when activated); and
wherein the activator includes at least one first locking mechanism (142) and the frame includes at least one second locking mechanism (150), and wherein the at least one first locking mechanism is configured to engage the at least one second locking mechanism after the activator is moved to the activated position to maintain the activator in the activated position (Depicted in Fig. 9, Col. 9, lines 4-8, locks in activated position).
Re: Claim 2, Carter discloses the claimed invention including the activator has a positioning slot (75) configured to receive the injection tool so as to facilitate a precise connection between the actuator and the injection tool (Fig. 1-2, Col. 6, lines 1-7, positioned slot for injection tool connection).
Re: Claim 4, Carter discloses the claimed invention including the activator is injection molded as one part (Fig. 7, Col. 9, lines 55-61, integral injection molded part).
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. References cited on the PTO-892.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHARLES P. CHEYNEY whose telephone number is (571)272-9971. The examiner can normally be reached Monday - Friday, 8:00 am - 4:30 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Paul Durand can be reached at 571-272-4459. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/CHARLES P. CHEYNEY/Primary Examiner, Art Unit 3754